Excess costs of medical care 1 and 8 years after diagnosis of diabetes:: estimates from young and middle-aged incidence cohorts in Sweden

被引:18
作者
Jonsson, PM [1 ]
Marké, LÅ
Nyström, L
Wall, S
Östman, J
机构
[1] Karolinska Inst, IHCAR, Dept Publ Hlth Sci, Div Int Hlth, SE-17176 Stockholm, Sweden
[2] SBU, Swedish Council Technol Assessment Hlth Care, Stockholm, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[4] Karolinska Inst, Huddinge Hosp, Dept Med, S-10401 Stockholm, Sweden
关键词
diabetes care; costs and cost analysis; health services/utilization; Sweden;
D O I
10.1016/S0168-8227(00)00161-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To analyze the excess costs of medical care during the first decade after diabetes diagnosis, we surveyed two national incidence cohorts who contracted diabetes at age of 15-34 years and matched control groups from the general population of Sweden. Ninety percent of the diabetic subjects were on insulin treatment. Data on healthcare utilization and use of glucose lowering drugs and medical devices were collected via a questionnaire mailed to a recent cohort 1 year after diagnosis and a previously registered cohort 8 years after diagnosis. Costing was based on average national costs of hospital inpatient and out-patient care, an original study of daycare costs, and sales prices of the National Corporation of Swedish Pharmacies. One year after diabetes diagnosis, the annual excess costs of care were US$4743 among men and US$4976 among women (1997 prices). Hospital inpatient care accounted for more than 50% of the excess costs. Eight years after diagnosis, the excess costs were US$2010 among men and US$2734 among women. The higher costs for women were mainly related to hospital out-patient care. but also to more intensive self-monitoring. We conclude that diabetes in young and middle-aged people is a major economic challenge even before significant complications may have developed. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 47
页数:13
相关论文
共 29 条
[1]   DIFFICULTIES IN CLASSIFYING DIABETES AT PRESENTATION IN THE YOUNG-ADULT [J].
ARNQVIST, HJ ;
LITTORIN, B ;
NYSTROM, L ;
SCHERSTEN, B ;
OSTMAN, J ;
BLOHME, G ;
LITHNER, F ;
WIBELL, L .
DIABETIC MEDICINE, 1993, 10 (07) :606-613
[2]  
Berne C, 1997, Nord Med, V112, P151
[3]  
BERNE C, 1997, NORD MED, V112, P175
[4]   MALE PREDOMINANCE OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN YOUNG-ADULTS - RESULTS FROM A 5-YEAR PROSPECTIVE NATIONWIDE STUDY OF THE 15-34-YEAR AGE GROUP IN SWEDEN [J].
BLOHME, G ;
NYSTROM, L ;
ARNQVIST, HJ ;
LITHNER, F ;
LITTORIN, B ;
OLSSON, PO ;
SCHERSTEN, B ;
WIBELL, L ;
OSTMAN, J .
DIABETOLOGIA, 1992, 35 (01) :56-62
[5]  
*FASS, 1992, PHARM PROD SWED 1993
[6]  
*FED COUNT COUNC, 1993, COSTS ADM PAT BED DA
[7]   THE COST OF DIABETES [J].
GERARD, K ;
DONALDSON, C ;
MAYNARD, AK .
DIABETIC MEDICINE, 1989, 6 (02) :164-170
[8]   The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales [J].
Gray, A ;
Fenn, P ;
McGuire, A .
DIABETIC MEDICINE, 1995, 12 (12) :1068-1076
[9]   A simulation model of the cost of the incidence of IDDM in Spain [J].
Hart, WM ;
Espinosa, C ;
Rovira, J .
DIABETOLOGIA, 1997, 40 (03) :311-318
[10]   Diabetes:: the cost of illness in Sweden [J].
Henriksson, F ;
Jönsson, B .
JOURNAL OF INTERNAL MEDICINE, 1998, 244 (06) :461-468